Severine Mouraud

Villejuif, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

VEGF-A blockade overcomes liver metastases resistance to chemoimmunotherapy in patients with advanced non-squamous NSCLC.

VEGF-A blockade overcomes liver metastases resistance to chemoimmunotherapy in patients with advanced non-squamous NSCLC.

Journal: Journal for immunotherapy of cancer

Published: May 05, 2026

Cytokines released by human tumors are independent from cancer histotype.

Cytokines released by human tumors are independent from cancer histotype.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 10, 2025

Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1.

Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1.

Journal: Nature

Published: August 17, 2025

Correction: Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers.

Correction: Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers.

Journal: Cell death & disease

Published: February 14, 2024

Immune checkpoints are predominantly co-expressed by clonally expanded CD4+FoxP3+ intratumoral T-cells in primary human cancers.

Immune checkpoints are predominantly co-expressed by clonally expanded CD4+FoxP3+ intratumoral T-cells in primary human cancers.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 14, 2023

Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma.

Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma.

Journal: Cancer discovery

Published: August 08, 2022

Feasibility, safety and efficacy of human intra-tumoral immuno-therapy. Gustave Roussy's initial experience with its first 100 patients.

Feasibility, safety and efficacy of human intra-tumoral immuno-therapy. Gustave Roussy's initial experience with its first 100 patients.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 07, 2022

Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers.

Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 31, 2021

CD8+ T Lymphocytes Immune Depletion and LAG-3 Overexpression in Hodgkin Lymphoma Tumor Microenvironment Exposed to Anti-PD-1 Immunotherapy.

CD8+ T Lymphocytes Immune Depletion and LAG-3 Overexpression in Hodgkin Lymphoma Tumor Microenvironment Exposed to Anti-PD-1 Immunotherapy.

Journal: Cancers

Published: July 19, 2021

Neuropilin-1 cooperates with PD-1 in CD8+ T cells predicting outcomes in melanoma patients treated with anti-PD1.

Neuropilin-1 cooperates with PD-1 in CD8+ T cells predicting outcomes in melanoma patients treated with anti-PD1.

Journal: iScience

Published: February 21, 2021

Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers.

Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers.

Journal: Cell death & disease

Published: November 24, 2020

BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer.

BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer.

Journal: The Journal of clinical investigation

Published: November 02, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026